Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Prostatectomy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05679193
What this trial is testing

Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence

Who this might be right for
Prostate Cancer
Oslo University Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05826509
What this trial is testing

SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Claudius Regaud 240
Not applicableLooking for participantsNCT06822452
What this trial is testing

Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an Outpatient Versus an Inpatient Procedure.

Who this might be right for
Prostate Cancer SurgeryAmbulatory CareOutpatient Surgery
Elsan 510
Not applicableStudy completedNCT07333807
What this trial is testing

Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy

Who this might be right for
Prostate CancerRadical Prostatectomy
Tri-Service General Hospital (TSGH) 60
Not applicableEnded earlyNCT03256630
What this trial is testing

Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

Who this might be right for
Prostate Cancer
Genomic Health®, Inc. 128
Not applicableStudy completedNCT00513721
What this trial is testing

Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy

Who this might be right for
Prostate Cancer
Corewell Health East 400
Early research (Phase 1)Looking for participantsNCT06631521
What this trial is testing

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate CAProstate Cancer (Adenocarcinoma)Prostate Cancer Surgery
AdventHealth 30
Very early researchWithdrawnNCT05567679
What this trial is testing

Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Edwin Posadas, MD
Testing effectiveness (Phase 2)Study completedNCT01867424
What this trial is testing

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 24
Not applicableNot Yet RecruitingNCT07444983
What this trial is testing

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fujian Medical University Union Hospital 33
Not applicableUnknownNCT03351088
What this trial is testing

Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 226
Not applicableActive Not RecruitingNCT07262073
What this trial is testing

Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy

Who this might be right for
Prostate Cancer (CRPC)Peak Expiratory Flow
Ankara City Hospital Bilkent 60
Early research (Phase 1)Study completedNCT02119858
What this trial is testing

Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery

Who this might be right for
Stage IIA Prostate CancerStage IIB Prostate Cancer
City of Hope Medical Center 20
Large-scale testing (Phase 3)WithdrawnNCT02260349
What this trial is testing

Interest of Indocyanine Green in Neoplastic Prostatic Tissue

Who this might be right for
Prostatic Neoplasms
Centre Hospitalier Universitaire de Saint Etienne
Not applicableActive Not RecruitingNCT03663218
What this trial is testing

PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 16
Early research (Phase 1)Study completedNCT01912820
What this trial is testing

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+4 more
Jonsson Comprehensive Cancer Center 32
Not applicableLooking for participantsNCT07826858
What this trial is testing

SPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer

Who this might be right for
Localized Prostate CancerPositive Surgical MarginHyperspectral Imaging
Massimo Valerio 26
Not applicableNot Yet RecruitingNCT06844513
What this trial is testing

Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform

Who this might be right for
Prostate Cancer (Adenocarcinoma)Renal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 800
Not applicableUnknownNCT06152679
What this trial is testing

Day-case Endourology; Patient Experience

Who this might be right for
Bladder CancerBladder Outflow Obstruction
Royal Devon and Exeter NHS Foundation Trust 15
Testing effectiveness (Phase 2)Looking for participantsNCT05593497
What this trial is testing

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Who this might be right for
High-Risk Prostate Cancer
VA Office of Research and Development 30
Next Page